Xaira Therapeutics
Foundation-model-driven pipeline built on generative protein design and perturbation data.
Full Xaira Therapeutics record →Head to head
Xaira Therapeutics vs Chai
Xaira Therapeutics (Xaira Therapeutics) and Chai (Chai Discovery) both sit in Science & Bio. Chai shipped more tracked changes in the last 30 days (9 vs 6). Every value below comes from the latest crawl of the vendors' own pages.
| Attribute | Xaira Therapeutics Xaira Therapeutics | Chai Chai Discovery |
|---|---|---|
| Segment | Science & Bio | Science & Bio |
| Version | X-Atlas/Pisces and X-Cell | 1 |
| Entry cost | Enterprise/proprietary drug discovery platform, no public pricing or individual tiers | Pricing is not publicly disclosed (enterprise/license agreements) |
| Pricing tiers | — | — |
| Model stack | Proprietary | Chai-1 · Chai-2 |
| Context window | — | — |
| Public API | ||
| Routes models | ||
| Changes / 30d | 6 | 9 |
| Origin | United States | United States |
| Capabilities | Generative protein design, Perturbation atlases, Wet-lab loop, predictive AI models, agentic AI models, virtual cells, drug discovery, AI models for drug discovery | De novo binders, Complex prediction, Antibody design, Web tool, drug discovery, molecule design, antibody discovery, molecular design |
Chai
Structure prediction and de novo binder design aimed at drug programs.
Full Chai record →